Home > PJ (current issue) > The Society / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7210 p197
10 August 2002


Your views sought on eligibility to serve on — and remain on — the Council

This article (PDF 151K)

A discussion paper issued by the Royal Pharmaceutical Society this week asks for views on how the elected membership of the Society’s Council should be controlled. It seeks opinions on restricting eligibility for election, on limiting length of service and on removing Council members for poor attendance, conduct or performance. It also asks for views on canvassing, the frequency of elections and the length of the term of office.

Published as a four-page centre pull-out section with this issue of The Journal (facing p200, the paper is the third in a series prepared by the Society’s Modernisation Steering Group to promote discussion and comment from those with an interest in the Society’s governance. Their publication follows a Council decision that the Society should retain both its regulatory and professional roles within a reformed structure based on public interest (PJ, May 25, p739).

The first paper (PJ, 15 June, p855), sought views on the Council’s future responsibilities and composition, including the proportions of professional and lay members. The second (PJ, 22 June, p883) looked at whether the Council’s make-up should reflect devolution and/or fields of practice and whether at least some pharmacist members of the Council should be appointed. It also considered the election voting system.

Comments on the third paper are sought by 13 September. The Journal is to distribute a questionnaire with the 24 August issue to obtain a snapshot response to the questions raised in the paper.

The new paper compares the Society’s current position with the existing or proposed electoral schemes of the bodies regulating other health professions: the General Chiropractic Council (GCC), General Dental Council (GDC), General Medical Council (GMC), General Optical Council (GOC), General Osteopathic Council (GOsC), Health Professions Council (HPC) and Nursing and Midwifery Council (NMC). While acknowledging that the Society is not directly equivalent to any of those bodies, it points out that the gap between the Society’s remit and those of the other bodies will diminish as they expand their activities to meet the broadening concept of modern regulation. In addition, it says, the Council for the Regulation of Health Care Professionals will want consistency between the bodies regulating health professionals.

In a section on eligibility for election to the Council, the paper asks whether the existing criteria should change. Currently, the only restrictions on eligibility are that a candidate must be “normally resident” in Britain, the Isle of Man or the Channel Islands and must be nominated by 10 pharmacists, five of them from his own branch.

On residency, the paper suggests that a simpler criterion than “normally resident” might be to restrict eligibility on the basis of registered address. The GCC and GMC require a registered address in the United Kingdom, while the HPC and NMC require candidates to live or work mainly in the UK.

On the requirement for five nominators to be from the candidate’s branch, the paper says that although this could be argued to demonstrate that the candidate has some local standing, it could disadvantage candidates from specialist areas of practice or those with national rather than local reputations. Apart from a GCC stipulation that candidates require five nominators within their home country, the paper gives no examples of similar requirements in other professions.

The paper also asks for views on whether possible conflicts of interest should require a restriction on eligibility for pharmacists who serve on other pharmacy bodies. It notes that other health care regulators generally do not have such a restriction.

The paper asks whether candidates should have to declare any adverse decisions on their fitness to practise, pointing out that the profession’s reputation might be damaged if such information became known only after someone had taken up their Council seat. Five of the other regulatory bodies require disclosure of such information.

The paper goes on to ask whether candidates should have to be actively working in pharmacy. The HPC and NMC both require that candidates “continue to practise, teach, manage or research within their profession”.

The paper asks whether candidates should have to declare their eligibility to serve as charity trustees, since Council members are trustees of charitable funds such as the Benevolent Fund. Because it is a criminal offence to serve as a trustee when disqualified from doing so under the terms of the Charities Act 1993, the paper suggests that such a requirement would be sensible.

In a section on canvassing, the paper asks for views on whether the current restrictions should change. It gives no information about the situation in other health case professions.

The paper goes on to ask for views on the term of office of Council members. It suggests that the current three-year term might be considered too short in view of the need to gain experience before a member can exert influence. Other health care regulators have, or will have, terms of four or five years, and the Committee on Standards in Public Life recommends a four-year limit.

On the frequency of elections, it says that electing only one-third of the Council each year provides continuity but also limits the impact of the election. Other regulatory bodies vary in the frequency of their elections.

The paper then asks for views on limiting the number of consecutive terms of office a Council member may serve. It says that the Committee on Standards in Public Life recommends a normal limit of two terms of office. Among other health care regulatory bodies, the GMC will have a limit of two four-year terms and the HPC and NMC will have a limit of three three-year terms. The other regulators will have no limit.

Another question raised is whether there should be an age limit for Council members. Of the other six regulatory bodies, three have opted for no limit, two for a 70-year limit and one for a limit of 65 years for serving members and 60 years for candidates.

Finally, the paper asks about changing the ways in which Council members may be removed from office. It suggests that the Council needs a mechanism to remove members who hinder it in carrying out its responsibilities. Three of the other regulators have legislative mechanisms allowing the removal of a council member in circumstances such as repeated absence from meetings, unacceptable professional conduct or bringing the council into disrepute. And three would be able to remove or suspend council members because of fitness-to-practise decisions.

• The discussion paper can also be downloaded in PDF format from the “About the Society” section of the Society’s website (www.rpsgb.org.uk/society).

 


  * PDF files on PJ Online require Acrobat Reader 4 or later.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal